PATENT CLAIM ANALYSIS

Application Number: 15953725
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2019-01
Patent Classification: ["530", "300000"]

Abstract:
Pharmaceutical formulations comprising a clostridial derivative and a permeabilizing agent for intravesical instillation are disclosed.

Claim (Index 15):
The method of  claim 9 , wherein the clostridial derivative is a botulinum toxin type A.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 91.0
- Lexical Diversity: 1.06667
- Patent Class: 530.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14700390', '14054731', '13566804', '14055749', '11195268']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7036267720859986
- 35 USC 102 Novelty (BERT): 0.6276442535284582
- Combined Prediction Score: 0.6960285202302445
- Mean Citation Score: 355.130462
- Max Citation Score: 733.2744
- Similarity Product: 508.5410370523453

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test